Search research articles
Contact Us
Filters
Showing results (41-50 of 51) with videos related to
Page
of 6
Sort By:
Communications Medicine
|
January 20, 2026
5-methylcytosine and 5-hydroxymethylcytosine are synergistic biomarkers for early detection of colorectal cancer
Fabio Puddu, Annelie Johansson, Aurélie Modat, et al.
Scientific Reports
|
February 7, 2020
Integrative network modeling reveals mechanisms underlying T cell exhaustion
Hamid Bolouri, Mary Young, Joshua Beilke, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 27, 2022
Effect of peri-operative chemotherapy regimen on survival in the treatment of locally advanced oesophago-gastric adenocarcinoma - A comparison of the FLOT and 'MAGIC' regimens
Jonathan L Moore, Sacheen Kumar, Aida Santaolalla, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 30, 2006
Phase III trial of capecitabine plus oxaliplatin as adjuvant therapy for stage III colon cancer: a planned safety analysis in 1,864 patients
Hans-Joachim Schmoll, Thomas Cartwright, Josep Tabernero, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 20, 2013
A randomised phase III trial of the pharmacokinetic biomodulation of irinotecan using oral ciclosporin in advanced colorectal cancer: results of the Panitumumab, Irinotecan & Ciclosporin in COLOrectal cancer therapy trial (PICCOLO)
Gary Middleton, Sarah Brown, Catherine Lowe, et al.
Cancer Research
|
May 12, 2025
Systemic Inactivation of TREX1 Induces Selective Inflammation of the Tumor Microenvironment and Invigorated T Cell-Mediated Tumor Control
Emilija Marinkovic, Minyi Chen, Nadja Schubert, et al.
The Lancet. Oncology
|
June 4, 2013
Panitumumab and irinotecan versus irinotecan alone for patients with KRAS wild-type, fluorouracil-resistant advanced colorectal cancer (PICCOLO): a prospectively stratified randomised trial
Matthew T Seymour, Sarah R Brown, Gary Middleton, et al.
Clinical Colorectal Cancer
|
October 26, 2021
Trifluridine/Tipiracil in Metastatic Colorectal Cancer: A UK Multicenter Real-world Analysis on Efficacy, Safety, Predictive and Prognostic Factors
Chara Stavraka, Athanasios Pouptsis, Alicja Synowiec, et al.
Journal of Medicinal Chemistry
|
November 27, 2023
Identification of Small Molecule Inhibitors and Ligand Directed Degraders of Calcium/Calmodulin Dependent Protein Kinase Kinase 1 and 2 (CaMKK1/2)
Young Chen, Brandon Whitefield, Erin Nevius, et al.
The Journal of Pathology
|
November 15, 2023
Genetic and immune landscape evolution in MMR-deficient colorectal cancer
Benjamin R Challoner, Andrew Woolston, David Lau, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 51) with videos related to
Sort By:
Page
of 6
Communications Medicine
|
January 20, 2026
5-methylcytosine and 5-hydroxymethylcytosine are synergistic biomarkers for early detection of colorectal cancer
Fabio Puddu, Annelie Johansson, Aurélie Modat, et al.
Scientific Reports
|
February 7, 2020
Integrative network modeling reveals mechanisms underlying T cell exhaustion
Hamid Bolouri, Mary Young, Joshua Beilke, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 27, 2022
Effect of peri-operative chemotherapy regimen on survival in the treatment of locally advanced oesophago-gastric adenocarcinoma - A comparison of the FLOT and 'MAGIC' regimens
Jonathan L Moore, Sacheen Kumar, Aida Santaolalla, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 30, 2006
Phase III trial of capecitabine plus oxaliplatin as adjuvant therapy for stage III colon cancer: a planned safety analysis in 1,864 patients
Hans-Joachim Schmoll, Thomas Cartwright, Josep Tabernero, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 20, 2013
A randomised phase III trial of the pharmacokinetic biomodulation of irinotecan using oral ciclosporin in advanced colorectal cancer: results of the Panitumumab, Irinotecan & Ciclosporin in COLOrectal cancer therapy trial (PICCOLO)
Gary Middleton, Sarah Brown, Catherine Lowe, et al.
Cancer Research
|
May 12, 2025
Systemic Inactivation of TREX1 Induces Selective Inflammation of the Tumor Microenvironment and Invigorated T Cell-Mediated Tumor Control
Emilija Marinkovic, Minyi Chen, Nadja Schubert, et al.
The Lancet. Oncology
|
June 4, 2013
Panitumumab and irinotecan versus irinotecan alone for patients with KRAS wild-type, fluorouracil-resistant advanced colorectal cancer (PICCOLO): a prospectively stratified randomised trial
Matthew T Seymour, Sarah R Brown, Gary Middleton, et al.
Clinical Colorectal Cancer
|
October 26, 2021
Trifluridine/Tipiracil in Metastatic Colorectal Cancer: A UK Multicenter Real-world Analysis on Efficacy, Safety, Predictive and Prognostic Factors
Chara Stavraka, Athanasios Pouptsis, Alicja Synowiec, et al.
Journal of Medicinal Chemistry
|
November 27, 2023
Identification of Small Molecule Inhibitors and Ligand Directed Degraders of Calcium/Calmodulin Dependent Protein Kinase Kinase 1 and 2 (CaMKK1/2)
Young Chen, Brandon Whitefield, Erin Nevius, et al.
The Journal of Pathology
|
November 15, 2023
Genetic and immune landscape evolution in MMR-deficient colorectal cancer
Benjamin R Challoner, Andrew Woolston, David Lau, et al.
Page
of 6